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BACKGROUND: It is increasingly recognised that host-related factors may be important in determining cancer outcome. The aim was to
examine the relationship between patient physiology, the systemic inflammatory response and survival after colorectal cancer
resection.
METHODS: Patients undergoing potentially curative resection of colorectal cancer were identified from a prospectively maintained
database. Patient physiology was assessed using the physiological and operative severity score for the enumeration of mortality and
morbidity (POSSUM) criteria. The systemic inflammatory response was assessed using the modified Glasgow Prognostic Score
(mGPS). Multivariate 5-year survival analysis was carried out with calculation of hazard ratios (HR).
RESULTS: A total of 320 patients were included. During follow-up (median 74 months), there were 136 deaths: 83 colorectal cancer
related and 53 non-cancer related. Independent predictors of cancer-specific survival were age (HR: 1.46, Po0.01), Dukes stage
(HR: 2.39, Po0.001), mGPS (HR: 1.78, Po0.001) and POSSUM physiology score (HR: 1.38, P¼0.02). Predictors of overall survival
were age (HR: 1.64, Po0.001), smoking (HR: 1.52, P¼0.02), Dukes stage (HR: 1.64, Po0.001), mGPS (HR: 1.60, Po0.001) and
POSSUM physiology score (HR: 1.27, P¼0.03). A relationship between mGPS and POSSUM physiology score was also established
(Po0.006).
CONCLUSION: The POSSUM physiology score and the systemic inflammatory response are strongly associated and both are
independent predictors of cancer specific and overall survival in patients undergoing potentially curative resection of colorectal
cancer.
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Colorectal cancer is the second most common cause of cancer
death in Western Europe and North America. Each year, in the
United Kingdom, there are approximately 35000 new cases and
the disease accounts for over 16000 deaths (http://www.
cancerresearchuk.org). Overall survival is poor; even in patients
who undergo resection with a curative intent, only half will be alive
at 5 years (McArdle and Hole, 2002; Verdecchia et al, 2008).
Following curative resection, the prognostic stratification and
provision of adjuvant therapy has traditionally been guided by the
pathological analysis of the tumour (Figueredo et al, 2008). It is
increasingly recognised, however, that pathological stage is not
the sole determinant of outcome. Host-related factors, in particular
the systemic inflammatory response, have proven important in
determining outcome. There is now a considerable body of
evidence that markers of systemic inflammation (in particular,
C-reactive protein, albumin and their combination in the modified
Glasgow Prognostic Score (mGPS)) can predict cancer-specific
survival in patients undergoing curative resection of colorectal
cancer (Roxburgh and McMillan, 2010a). This effect appears
independent of TNM stage and other high-risk pathological features
(Ishizuka et al, 2007; Koike et al, 2008; Roxburgh et al, 2009).
The basis of the relationship between systemic inflammation
and survival is not clear and it has yet to be established which host
characteristics, if any, an elevated inflammatory response may
represent. It is of interest that a systemic inflammatory response
has been reported to predict cardiac events (Lloyd-Jones and Levy,
2003) and is associated with patient-related factors such as obesity
(Ridker et al, 2003), diabetes (Dehghan et al, 2007) and smoking
(Fro ¨hlich et al, 2003). One hypothesis, therefore, is that a pre-
operative systemic inflammatory response may reflect the
existence of co-morbid disease (Roxburgh and McMillan, 2010b)
or altered patient physiology. Indeed, several studies have reported
elevated physiological and operative severity score for the
enumeration of mortality and morbidity (POSSUM) physiology
scores to be associated with poorer long-term survival in patients
undergoing surgery for colorectal cancer (Brosens et al, 2006;
Jenkins et al, 2007).
The aim of this study was to examine the relationship between
patient physiology, the systemic inflammatory response and
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colorectal cancer.
MATERIALS AND METHODS
Patients with histologically proven colorectal cancer who, on the
basis of laparotomy findings and pre-operative staging CT scan,
were considered to have undergone potentially curative resection
for colorectal cancer (Stages I–III) between January 1997 and
December 2006 in a single surgical unit at Glasgow Royal Infirmary
were included in the study. This cohort was identified from a
prospectively maintained database and included both elective and
emergency operations. Patients with conditions known to acutely
or chronically evoke a systemic inflammatory response were
excluded. These were (i) pre-operative chemo-radiotherapy,
(ii) clinical evidence of infection and (iii) chronic active inflam-
matory disease such as active rheumatoid arthritis. Patients who
died within 30 days of surgery were excluded from the survival
analysis. The tumours were staged according to conventional
Dukes classification (Williams et al, 2007).
Prospectively collected data included patient demographics,
pathological characteristics of the tumour, haemotology and
biochemistry results. The medical notes were then retrieved and
data extracted on patient co-morbidity and physiological status.
The case notes included surgical pre-operative assessment,
including details of known co-morbid disease and smoking status,
anaesthetic assessment, including cardiovascular evaluation and
ECG interpretation, nursing notes and drug prescription charts.
Deprivation was defined using the Carstairs Deprivation
Index (Carstairs and Morris, 1991). This is composed of four
indicators of deprivation (car ownership, overcrowded housing,
Registrar General social class and male unemployment) and
has been validated for use within central Scotland (Hole and
McArdle, 2002). Deprivation scores were based on the postcode
of the patients’ residence at the time of surgery (http://
www.isdscotland.org).
The development and rationale behind the Glasgow Prognostic
Score has been described previously (Forrest et al, 2003; McMillan,
2008). Briefly, patients with both an elevated C-reactive protein
(410mgl
–1) and hypoalbuminaemia (o35gl
–1) were allocated
a score of ‘2’. Patients in whom neither of these abnormalities
was present were allocated a score of ‘0’. In line with the recent
modification of the Glasgow Prognostic Score, patients with
an elevated C-reactive protein alone were assigned a score of
‘1’, whereas those with hypoalbuminaemia alone were assigned a
score of ‘0’. All measurements of C-reactive protein and albumin
were taken on admission prior to surgery.
Patient physiology was assessed by scoring patients according to
the original POSSUM criteria (Copeland et al, 1991). Age was
excluded from the physiological component of POSSUM and
analysed as an independent variable, in line with previous similar
studies (Tekkis et al, 2004; Brosens et al, 2006; Jenkins et al, 2007).
The remaining 11 physiological parameters (cardiac disease,
respiratory disease, ECG changes, pulse, blood pressure, haemo-
globin, white cell count, sodium, potassium, urea and Glasgow
Coma Scale) were used to construct a POSSUM physiology score
(Table 1). Patients were then assigned to one of four groups (score
11–14, 15–20, 21–30, 430) as previously described (Tekkis et al,
2004).
Patients received regular follow-up (3 months, 6 months and
then annually to 5 years) with CT scanning each year and regular
colonoscopic surveillance until 5 years post-surgery. Information
on date and cause of death was cross-checked with that received
by the cancer registration system and the Registrar General
(Scotland). Death records were complete until 31 August 2009,
which served as the censor date for the survivors. Cancer-specific
survival evaluated deaths only as a direct result of colorectal cancer
in the follow-up period, whereas overall survival analysis evaluated
deaths from any cause. Survival was measured from the date of
surgery to the date of death.
The study was approved by the Research Ethics Committee,
Glasgow Royal Infirmary, Glasgow.
Statistics
Grouping of the variables was carried out using standard or
previously published thresholds. Deaths up to September 2009
were included in the analysis. Univariate survival analysis with
calculation of hazard ratios (HR) and 95% confidence intervals was
carried out using the Cox proportional hazard model. A P-value of
o0.05 was considered statistically significant. Multivariate survival
analysis, using the Cox model and a stepwise backwards procedure,
was carried out for all variables showing a significant association
on univariate analysis. To remove a variable from the model, the
corresponding P-value had to be 40.1. Inter-relationships between
Table 1 Physiological variables used in the construction of the POSSUM physiology score
POSSUM physiology score 1 2 4 8
Cardiac Normal Cardiac drugs Oedema
warfarin
JVP
cardiomegaly
Respiratory Normal SOB exertion
Mild COPD
SOB stairs
Mod COPD
SOB rest
fibrosis
ECG Normal — AF (60–90) Other abnormality
Systolic BP (mmHg) 110–130 131–170 X171 p89
100–109 90–99
Pulse (beats per minute) 50–80 81–100 101–120 X120
40–49 p39
Haemoglobin (gdl
–1) 13–16 11.5–12.9 10–11.4 p9.9
16.1–17 17.1–18 X18.1
White cell count ( 10
12 per litre) 4–10 10.1–20 X20.1 —
3.1–3.9 p3
Sodium (mmoll
–1) X136 131–135 126–130 p125
Potassium (mmoll
–1) 3.5–5 3.2–3.4 2.9–3.1 p2.8
5.1–5.3 5.4–5.9 X6
Urea (mmoll
–1) p7.5 7.6–10 10.1–15 X15.1
GCS 15 12–14 9–11 p8
Abbreviations: AF¼atrial fibrillation; BP¼blood pressure; COPD¼chronic obstructive pulmonary disease; GCS¼glasgow coma score; JVP¼jugular venous pressure;
POSSUM¼physiological and operative severity score for the enumeration of mortality and morbidity; SOB¼shortness of breath. Age is excluded from the physiology score and
is analysed as an independent variable.
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w
2 test for trend as appropriate. Analysis was performed using SPSS
software (Version 15.0. SPSS Inc., Chicago, IL, USA).
RESULTS
Baseline clinico-pathological characteristics for all 320 patients who
underwent potentially curative resection for colorectal cancer are
shown in Table 2. All elective operations were carried out by one of
four colorectal surgeons, whereas emergency operations were carried
out by on-call general surgeons. All operations were open resections
with operative technique at the discretion of individual surgeons.
The majority of patients were aged 65 years or older (65%), lived in
deprived areas (65%) and were current or previous smokers (58%).
There was a significant association between smoking history (current
or ex) and increasing deprivation (P¼0.04). The majority of patients
underwent elective operations (96%), had colonic tumours (62%),
had well to moderately differentiated tumours (89%) and had node
negative disease (60%). The distribution of patients by systemic
inflammatory response (mGPS) and POSSUM physiology score is
shown in Table 2.
The minimum follow-up was 32 months; the median follow-up
of the survivors was 74 months. During this period, 83 patients
died of colorectal cancer and there were 53 non-cancer-related
deaths. The relationship between clinico-pathological character-
istics and cancer-specific survival is shown in Table 2. On
univariate analysis, age (P¼0.001), smoking history (P¼0.04),
presentation (Po0.001), Dukes stage (Po0.001), mGPS (Po0.001)
and POSSUM physiology score (Po0.001) were significantly
associated with cancer-specific survival. The relationship between
clinico-pathological characteristics and overall survival is also
shown in Table 2. On univariate analysis, age (Po0.001), smoking
history (P¼0.004), presentation (P¼0.001), Dukes stage
(P¼0.004), mGPS (Po0.001) and POSSUM physiology score
(Po0.001) were significantly associated with overall survival. The
Kaplan–Meier survival curves showing the relationship between
POSSUM physiology score and both cancer specific (Po0.001; log-
rank test) and overall survival (Po0.001; log-rank test) are shown
in Figures 1 and 2, respectively.
On multivariate analysis, age (HR: 1.46, Po0.001), emergency
presentation (HR: 2.08, P¼0.08), Dukes stage (HR: 2.39,
Po0.001), mGPS (HR: 1.78, Po0.001) and POSSUM physiology
score (HR: 1.38, P¼0.02) were independently associated with
cancer-specific survival, whereas age (HR: 1.64, Po0.001),
smoking history (HR: 1.52, P¼0.02), Dukes stage (HR: 1.64,
Po0.001), mGPS (HR: 1.60, Po0.001) and POSSUM physiology
score (HR: 1.27, P¼0.03) were independently associated with
overall survival (Table 3).
In the group of patients with Dukes C disease, we noted a
significant association between POSSUM physiology score and the
likelihood of adjuvant therapy being administered (w
2¼9.94,
df¼3, P¼0.019). Of the 129 patients with Dukes C disease, 46
patients (36%) received adjuvant therapy and 83 patients (64%)
did not. In patients with physiology score 11–14, 21 patients (51%)
received adjuvant therapy; physiology score 15–20, 19 patients
(35%) received adjuvant therapy; physiology score 21–30, 6
patients (21%) received adjuvant therapy; physiology score 430,
no patient received adjuvant therapy. There was no significant
association between the systemic inflammatory response and the
likelihood of adjuvant therapy being administered in patients with
Dukes C disease (w
2¼4.73, df¼2, P¼0.094).
The relationships between POSSUM physiology score and
clinico-pathological characteristics are shown in Table 4. The
POSSUM physiology score was significantly related to all its
component variables except potassium level (P¼0.11) and
Glasgow Coma Scale, the latter of which was uniformly normal.
The individual physiological variables that contributed most to
elevated POSSUM physiology score were haemoglobin level
(abnormal in 202 out of 320), systolic blood pressure (abnormal
in 192 out of 320) and cardiac function (impaired in 166 out of
320). Those that contributed least were sodium level (abnormal in
25 out of 320), potassium level (abnormal in 21 out of 320) and
GCS (abnormal in 0 out of 320). A higher POSSUM physiology
score was also significantly associated with increasing age
Table 2 The relationship between clinico-pathological variables and
survival in patients undergoing potentially curative resection for colorectal
cancer; univariate survival analysis
Cancer-specific
survival
Overall
survival
Variable 320 (%)
Hazard
ratio
(95% CI) P-value
Hazard
ratio
(95% CI) P-value
Age
p64 111 (35)
65–74 102 (32)
X75 107 (33) 1.66 (1.26, 2.18) 0.001 1.80 (1.45, 2.23) o0.001
Sex
Male 170 (53)
Female 150 (47) 1.30 (0.84, 2.01) 0.25 1.18 (0.84, 1.66) 0.34
Deprivation
1–2 12 (4)
3–5 99 (31)
6–7 209 (65) 1.11 (0.74, 1.65) 0.46 0.98 (0.72, 1.32) 0.77
Smoking
Never 135 (42)
Current/previous 185 (58) 1.62 (1.02, 2.55) 0.04 1.67 (1.17, 2.39) 0.004
Presentation
Elective 307 (96)
Emergency 13 (4) 3.93 (1.80, 8.56) o0.001 3.00 (1.53, 5.94) 0.001
Tumour site
Colon 197 (62)
Rectum 123 (38) 0.84 (0.53, 1.32) 0.45 1.09 (0.77, 1.54) 0.62
Differentiation
Well/
moderate
286 (89)
Poor 34 (11) 1.26 (0.63, 2.52) 0.51 1.58 (0.96, 2.59) 0.07
Dukes stage
Dukes A 38 (12)
Dukes B 153 (48)
Dukes C 129 (40) 2.21 (1.51, 3.21) o0.001 1.60 (1.21, 2.10) 0.004
Adjuvant therapy
No 254 (79)
Yes 66 (21) 1.00 (0.59, 1.69) 0.99 0.90 (0.59, 1.37) 0.61
mGPS
Low (0) 194 (61)
Intermediate (1) 90 (28)
High (2) 36 (11) 1.71 (1.29, 2.27) o0.001 1.60 (1.28, 2.01) o0.001
POSSUM physiology score
Group 1
(11–14)
109 (34)
Group 2
(15–20)
134 (42)
Group 3
(21–30)
69 (21)
Group 4
(430)
8 (3) 1.73 (1.33, 2.25) o0.001 1.59 (1.29, 1.96) o0.001
Abbreviation: CI¼confidence interval.
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Dukes stage (Po0.05) (Table 4).
A significant relationship between POSSUM physiology score
and mGPS was established (P¼0.006) (Table 4). This relationship
was further examined by calculating the mean score for each of the
POSSUM component variables in patients within the mGPS groups
(Figure 3). The mGPS was significantly associated with the
individual physiological components of abnormal pulse rate
(P¼0.008), raised white cell count (P¼0.05), low sodium
(Po0.001), raised potassium (P¼0.01) and low haemoglobin
(o0.001).
DISCUSSION
The results of this study show that pre-operative measures of
impaired patient physiology, such as elevated POSSUM physiology
scores, are significantly associated with poorer cancer specific
and overall survival in patients undergoing potentially curative
resection of colorectal cancer. However, when considered with
age, Dukes stage, smoking status and the systemic inflammatory
response (mGPS), the POSSUM physiology score was reduced in
statistical significance. Although the POSSUM physiology score
was strongly associated with mGPS, multivariate survival analysis
showed that both were independent predictors, suggesting that
poor patient physiology alone cannot fully explain the relationship
between the pre-operative systemic inflammatory response and
reduced colorectal cancer survival.
The results of this study are consistent with previous work.
Jenkins et al (2007) reported that, using the same thresholds, there
was a significant association between an elevated POSSUM
physiology score and poorer cancer-specific survival in a cohort
of 432 patients with colorectal cancer. In addition, Brosens et al
(2006) reported that, in 542 colorectal cancer patients, there was a
similar association between POSSUM physiology score and 5 year
overall survival using low- and high-risk groups based on the
median physiology score.
Given that the POSSUM score was developed to predict post-
operative mortality and morbidity, the basis of this relationship
with long-term survival is not clear. One possible explanation is
that poor patient physiology is associated with an increased
likelihood of post-operative complications such as an anastomotic
leak; recognised to be associated with early recurrence and cancer
death, independent of tumour stage (McArdle et al, 2005; Jung
et al, 2008; Marra et al, 2009). Another possible explanation,
examined in this study, is that a pre-operative systemic inflam-
matory response reflects, in part, the existence of physiological
dysfunction (Roxburgh and McMillan, 2010b). It is of interest,
therefore, that Moyes et al (2009) recently reported that, in 455
patients undergoing colorectal cancer surgery, the pre-operative
mGPS was independently associated with an increased risk of
developing post-operative infectious complications. It remains to
be determined whether infectious complications are the basis of
the relationship between poor POSSUM physiology score, elevated
mGPS and poor cancer-specific survival in patients undergoing
resection of colorectal cancer. Of interest, we noted that patients
with deranged physiology were significantly more likely to receive
adjuvant therapy for Dukes C tumours. However, the provision of
adjuvant therapy was not a predictor of cancer specific or overall
survival on multivariate analysis in this cohort, suggesting that the
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Figure 1 The relationship between POSSUM physiology score and
cancer-specific survival in patients undergoing potentially curative resection
for colorectal cancer. Groups 1–4 are shown top to bottom (Po0.001;
log-rank test).
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Figure 2 The relationship between POSSUM physiology score overall
survival in patients undergoing potentially curative resection for colorectal
cancer. Groups 1–4 are shown top to bottom (Po0.001; log-rank test).
Table 3 The relationship between clinico-pathological variables and
survival in patients undergoing potentially curative resection for colorectal
cancer; multivariate survival analysis
Cancer-specific
survival
Overall
survival
Variable
Hazard ratio
(95% CI) P-value
Hazard ratio
(95% CI) P-value
Age 1.46 (1.10, 1.94) o0.001 1.64 (1.32, 2.05) o0.001
Smoking 1.46 (0.92, 2.32) 0.10 1.52 (1.06, 2.18) 0.02
Presentation 2.08 (0.91, 4.76) 0.08 1.70 (0.84, 3.45) 0.14
Dukes 2.39 (1.59, 3.59) o0.001 1.64 (1.22, 2.20) o0.001
mGPS 1.78 (1.32, 2.41) o0.001 1.60 (1.26, 2.02) o0.001
POSSUM physiology score 1.38 (1.05, 1.82) 0.02 1.27 (1.02, 1.58) 0.03
Abbreviations: CI¼confidence interval; mGPS¼modified Glasgow Prognostic Score;
POSSUM¼physiological and operative severity score for the enumeration of
mortality and morbidity.
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its relationship with chemotherapy.
Taken together with previous work, the results of this study pose
the question as to whether pre-operative optimisation of patient
physiology and down-regulation of the systemic inflammatory
response may be associated with improvements in long-term
survival in patients undergoing surgery for colorectal cancer. With
respect to patient physiology, the components that contributed
most to an increase in the POSSUM physiology score were
impaired cardiac function and low haemoglobin. This would
suggest that targeting these parameters would be a rational first
step in the pre-operative optimisation in these patients. Indeed,
there is already some evidence that the use of statins may improve
survival in patients with colorectal cancer, possibly by improve-
ment in cardiovascular status (Siddiqui et al, 2009). The attenu-
ation of the systemic inflammatory response and the improvement
of oxygen delivery to the tissues represent other possibilities.
In this study, the individual physiological components asso-
ciated with the mGPS were an elevated pulse rate, low haemoglobin
and high WCC, as well as the biochemical abnormalities of low
sodium and raised potassium. A possible explanation is that poor
cardiac function in these patients, combined with anaemia, may
lead to relative tissue hypoxia. Indeed, it is recognised that tissue
hypoxia is a potent stimulator of local and systemic inflammation
(Wouters, 2005; Zinkernagel et al, 2007). If this were to be the case,
it might be expected that the systemic inflammatory response would
be more closely associated with a direct measurement of cardio-
pulmonary reserve, that is cardiopulmonary exercise testing (Weber
et al, 1987). Further work is needed to define such relationships.
The results from this study have further implications. The
POSSUM scoring systems have already proven to be accurate in
predicting post-operative mortality (Senagore et al, 2004; Ferjani
et al, 2007) and morbidity (Menon and Farouk, 2002; Valenti et al,
2009) after colorectal cancer surgery. Clearly, a single scoring
system that would allow comparative audit of post-operative
mortality, highlight patients at risk of surgical complications and
predict long-term cancer survival, would be advantageous.
However, although it may be argued that the majority of variables
are routinely recorded as part of pre-operative assessment, the
POSSUM physiology score has 11 physiological components,
excluding age. In contrast, the mGPS has only two components
and is, therefore, easier to construct and may be less subject to
interpretative error. It remains to be determined whether the
POSSUM physiology score or the mGPS will be most useful
in predicting both short-term and long outcome in patients
undergoing surgery for colorectal cancer.
In summary, POSSUM physiology score and the systemic
inflammatory response were strongly associated and both were
independent predictors of cancer specific and overall survival in
patients undergoing potentially curative resection of colorectal
cancer.
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